A category worth backing, built by a team that has done the work.
Deep Medicine sits at the intersection of a large, growing market and a validated scientific platform, with the certifications and clinical network most early companies lack.
Why this, why now.
A real, growing market
Digital neuro-biomarkers are among the highest-momentum segments in digital health through 2033 (Grand View Research, 2026).
A validated scientific basis
Every biomarker stream is grounded in peer-reviewed literature and co-developed with senior academic neurologists.
Defensible multi-modal IP
Five biomarker streams, hospital-embedded validation and a longitudinal dataset combine into a position that compounds over years.
A clear EU regulatory path
CE Class I achieved; the Class IIa upgrade, DiGA and PECAN reimbursement pathways are the defined next objectives.
An experienced team and academic network
More than ten data and medical scientists, with an advisory board of named senior neurologists across Belgium, Luxembourg and Germany.
The confidential materials.
Detailed financials, the round structure and the data room are shared privately with qualified investors. Tell us a little about you and the team will be in touch.
Nothing on this page is an offer to sell or a solicitation to buy any security.